These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28556793)

  • 1. Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases.
    Breyholz HJ; Kopka K; Schäfers M; Wagner S
    Pharmaceuticals (Basel); 2017 May; 10(2):. PubMed ID: 28556793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators.
    Schwegmann K; Hohn M; Hermann S; Schäfers M; Riemann B; Haufe G; Wagner S; Breyholz HJ
    Bioconjug Chem; 2020 Apr; 31(4):1117-1132. PubMed ID: 32181649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET.
    Wagner S; Breyholz HJ; Faust A; Höltke C; Levkau B; Schober O; Schäfers M; Kopka K
    Curr Med Chem; 2006; 13(23):2819-38. PubMed ID: 17073631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging.
    Breyholz HJ; Wagner S; Faust A; Riemann B; Höltke C; Hermann S; Schober O; Schäfers M; Kopka K
    ChemMedChem; 2010 May; 5(5):777-89. PubMed ID: 20373323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.
    Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K
    J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.
    Butsch V; Börgel F; Galla F; Schwegmann K; Hermann S; Schäfers M; Riemann B; Wünsch B; Wagner S
    J Med Chem; 2018 May; 61(9):4115-4134. PubMed ID: 29660282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.
    Matusiak N; van Waarde A; Bischoff R; Oltenfreiter R; van de Wiele C; Dierckx RA; Elsinga PH
    Curr Pharm Des; 2013; 19(25):4647-72. PubMed ID: 23339739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.
    Schrigten D; Breyholz HJ; Wagner S; Hermann S; Schober O; Schäfers M; Haufe G; Kopka K
    J Med Chem; 2012 Jan; 55(1):223-32. PubMed ID: 22118188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
    Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
    Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
    Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.
    Hugenberg V; Breyholz HJ; Riemann B; Hermann S; Schober O; Schäfers M; Gangadharmath U; Mocharla V; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
    J Med Chem; 2012 May; 55(10):4714-27. PubMed ID: 22540974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation.
    Hugenberg V; Wagner S; Kopka K; Schäfers M; Schuit RC; Windhorst AD; Hermann S
    J Med Chem; 2017 Jan; 60(1):307-321. PubMed ID: 27981835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.
    Wagner S; Breyholz HJ; Law MP; Faust A; Höltke C; Schröer S; Haufe G; Levkau B; Schober O; Schäfers M; Kopka K
    J Med Chem; 2007 Nov; 50(23):5752-64. PubMed ID: 17956082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
    Kopka K; Breyholz HJ; Wagner S; Law MP; Riemann B; Schröer S; Trub M; Guilbert B; Levkau B; Schober O; Schäfers M
    Nucl Med Biol; 2004 Feb; 31(2):257-67. PubMed ID: 15013492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.
    Hugenberg V; Hermann S; Galla F; Schäfers M; Wünsch B; Kolb HC; Szardenings K; Lebedev A; Walsh JC; Mocharla VP; Gangadharmath UB; Kopka K; Wagner S
    Nucl Med Biol; 2016 Jul; 43(7):424-37. PubMed ID: 27179748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.
    Oltenfreiter R; Staelens L; Kersemans V; Cornelissen B; Frankenne F; Foidart JM; Van de Wiele C; Slegers G
    Appl Radiat Isot; 2006 Jun; 64(6):677-85. PubMed ID: 16546398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.